Clinical Trials Logo
  1. Home
  2. Depressive Episode
  3. NCT04383509

Electroconvulsive Treatment Followed by Cognitive Control Training — ECT-CCT  

Depressive Episode Clinical Trial

Official title:
Cognitive Remediation Following Electroconvulsive Therapy in Patients With Treatment Resistant Depression: Randomized Controlled Trail of an Intervention for Relapse Prevention

Clinical Trial Summary

Major depressive disorder (MDD) is worldwide one of the most prevalent and disabling mental health conditions. Electroconvulsive therapy (ECT) is a safe and effective treatment even though 6-month relapse rates are high. Cognitive side effects of ECT, such as reduced cognitive control, might trigger mechanisms that increase relapse in patients. As such, cognitive control training (CCT) holds promise as a non-pharmacological strategy to improve long-term effects of ECT (i.e., increase remission, and reduce depression relapse).

Clinical Trial Description

Eighty-eight participants aged between 18-70 years with major depressive disorder who start electroconvulsive treatment (ECT) will be included in this randomized controlled trial (RCT). Following (partial) response to ECT treatment (at least a 25% reduction of clinical symptoms), participants will be randomly assigned to a computer based CCT or active placebo control. A first aim of this RCT is to assess the effects of CCT compared to an active placebo condition on depression symptomatology, cognitive complaints, and quality of life. Secondly, participants will be monitored every two weeks for a period of six months following CCT/active placebo, allowing the detection of potential relapse of depression. Thirdly, the investigators will assess participant evaluation of the addition of cognitive remediation to ECT using qualitative interview methods (satisfaction, acceptability and appropriateness). Finally, in order to further advance the understanding of the mechanisms underlying effects of CCT, exploratory analyses may be conducted using facial video footage collected during the CCT/active control phase of the study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04383509
Study type Interventional
Source University Ghent
Contact
Status Terminated
Phase N/A
Start date May 10, 2020
Completion date July 1, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT04469322 - Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression N/A
Recruiting NCT02481245 - BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study Phase 2
Completed NCT03449979 - Single Session of tACS in a Depressive Episode N/A
Recruiting NCT05708222 - Sleep Signal Analysis for Current Major Depressive Episode (SAMDE)
Completed NCT01879111 - Increasing the Efficiency of Depression-screening Using Patient-targeted Feedback N/A
Unknown status NCT01212848 - Transcranial Magnetic Stimulation (TMS) for Suicidal Ideation Phase 3
Not yet recruiting NCT05547711 - Prediction and Validation of Unipolar Depression With Psychosocial-somatic Markers in a Naturalistic Cohort Recruited in an Outpatient Setting N/A
Completed NCT04239521 - The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
Completed NCT03288714 - Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder N/A
Completed NCT03899168 - Confirmation Bias Towards Treatments of Depressive Disorders in Social Tagging N/A
Terminated NCT03537547 - Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder Phase 4
Completed NCT05683028 - RCT for Electroconvulsive Treatment Followed by Cognitive Control Training N/A
Enrolling by invitation NCT05701345 - Study of Virtual Reality-based Medical Device for Patients With Depressive Disorder N/A
Recruiting NCT04123301 - Theta-Burst Stimulation in Major Depressive Episodes With Mixed Characteristics. N/A
Completed NCT05686408 - Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD) Phase 2
Completed NCT03543410 - A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression Phase 2
Completed NCT04953338 - Mental Health Associations With Vitiligo
Completed NCT05462652 - Self-guided Treatment for Adolescents Navigating Depression N/A
Recruiting NCT03944213 - Resting-state Functional Connectivity Throughout a Course of iTBS in Major Depression
Not yet recruiting NCT04658420 - A Single Ketamine Infusion Combined With Music for Suicidal Ideation Phase 2